Jeffrey Robert Ajer - 29 Apr 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
29 Apr 2022
Net transactions value
-$82,035
Form type
4
Filing time
31 May 2022, 21:29:57 UTC
Previous filing
14 Apr 2022
Next filing
07 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21,218 +340 +0.62% $62.41 55,417 29 Apr 2022 Direct F1
transaction BMRN Common Stock Sale $103,254 -1,308 -2.4% $78.94 54,109 26 May 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Trade made pursuant to a 10b5-1 plan executed on February 28, 2022.